1. Home
  2. COEP vs IDN Comparison

COEP vs IDN Comparison

Compare COEP & IDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • IDN
  • Stock Information
  • Founded
  • COEP 2017
  • IDN 1994
  • Country
  • COEP United States
  • IDN United States
  • Employees
  • COEP N/A
  • IDN N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • IDN Computer Software: Prepackaged Software
  • Sector
  • COEP Health Care
  • IDN Technology
  • Exchange
  • COEP Nasdaq
  • IDN Nasdaq
  • Market Cap
  • COEP 39.0M
  • IDN 46.8M
  • IPO Year
  • COEP N/A
  • IDN 1999
  • Fundamental
  • Price
  • COEP $9.31
  • IDN $3.23
  • Analyst Decision
  • COEP
  • IDN Buy
  • Analyst Count
  • COEP 0
  • IDN 2
  • Target Price
  • COEP N/A
  • IDN $3.50
  • AVG Volume (30 Days)
  • COEP 107.6K
  • IDN 69.1K
  • Earning Date
  • COEP 05-27-2025
  • IDN 05-13-2025
  • Dividend Yield
  • COEP N/A
  • IDN N/A
  • EPS Growth
  • COEP N/A
  • IDN N/A
  • EPS
  • COEP N/A
  • IDN N/A
  • Revenue
  • COEP N/A
  • IDN $20,211,000.00
  • Revenue This Year
  • COEP N/A
  • IDN $7.60
  • Revenue Next Year
  • COEP N/A
  • IDN $10.02
  • P/E Ratio
  • COEP N/A
  • IDN N/A
  • Revenue Growth
  • COEP N/A
  • IDN 4.55
  • 52 Week Low
  • COEP $2.31
  • IDN $1.92
  • 52 Week High
  • COEP $13.70
  • IDN $4.46
  • Technical
  • Relative Strength Index (RSI)
  • COEP 49.50
  • IDN 67.96
  • Support Level
  • COEP $7.81
  • IDN $2.47
  • Resistance Level
  • COEP $10.86
  • IDN $2.87
  • Average True Range (ATR)
  • COEP 1.45
  • IDN 0.20
  • MACD
  • COEP 0.09
  • IDN 0.05
  • Stochastic Oscillator
  • COEP 62.07
  • IDN 87.31

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About IDN Intellicheck Inc.

Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The products of the company include solutions for preventing identity fraud across any industry delivered via smartphone, tablet, POS integration or other electronic devices.

Share on Social Networks: